Delivery Order SPE2DB20D3103-SPE2DB22FM3W0

Award Date 1/24/22
Potential Completion Date 1/25/22
Potential Value $7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ganirelix Acetate, a pharmaceutical medication, to the Defense Logistics Agency (DLA). The $46,667.75 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has an ultimate completion date of April 6, 2023 and was awarded on April 5, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $7,980.49 firm fixed price delivery order is for the pharmaceutical product Ganirelix Acetate 250 mcg/0.5 mL, with a completion date of July 5, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025....
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FM5D2) under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is valued at up to $999,999,999.00 and runs through November 2026. This specific delivery order is for the pharmaceutical product Ganirelix Acetate 250 mcg/0.5 mL, with a ceiling value of $6,491.80 and a completion date of February 3, 2022. The contract is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $63,412.89 firm fixed-price delivery order is for GANIRELIX ACET 250 MCG/0.5 ML 0.5ML, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,316.39, is for the delivery of 4567461603 GANIRELIX ACET 250 MCG/0.5 ML 0.5ML, a specialty pharmaceutical product. The contract has a completion date of March 5, 2025 and is structured as a firm fixed price delivery order. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $99,411.03, is for the delivery of the drug Ganirelix Acetate, a medication used in fertility treatments. The contract has a firm fixed price pricing type and a period of performance through February 2025. No set-aside designation was used for this award....
The Defense Logistics Agency awarded a $6,975.00 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563265975 ! GANIRELIX ACET 250 MCG/0.5 ML 0.S ML. The delivery order is for pharmaceutical products to support Defense Logistics Agency Troop Support Medical programs and facilities. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals, medical supplies, and related...
This federal contract award, valued at $6,930.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Gonal-F RFF Redi-Ject 900 unit 1.5ml, a pharmaceutical product, with a completion date of June 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December...
The federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price of $15,942.66 and has an ultimate completion date of September 10, 2021. This award is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $83,437.62. This is a firm fixed-price delivery order contract with a period of performance ending on February 28, 2024. The contract was awarded on February 27, 2024, with no set-aside designation,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FM3W0
    Delivery Order

This federal contract award is for the delivery of Ganirelix Acetate 250 mcg/0.5 mL pharmaceutical products to the Defense Logistics Agency (DLA). The contract, worth $7,031.00, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract does not have any set-aside designations, indicating open competition.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.

Generated 2/27/25, 11:18 AM